Clinical Trial Update: Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid [NA]

View source ↗

Summary

This entry notes an ongoing clinical trial comparing fractional Erbium YAG laser treatment with intradermal and systemic tranexamic acid for refractory melasma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Fractional Erbium YAG Laser (erbium-doped yttrium aluminum garnet laser)
• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Egymedicalpedia | Conditions: Refractory Melasma | NA | Status: RECRUITING